Home » Medical Devices » Europe Peripheral Vascular Devices Market

Europe Peripheral Vascular Devices Market By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Guidewires, Others); By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $3699

Published: | Report ID: 70327 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period 2019-2022
Base Year 2023
Forecast Period 2024-2032
Europe Peripheral Vascular Devices Market Size 2023 USD 2,656.83 million
Europe Peripheral Vascular Devices Market, CAGR 5.85%
Europe Peripheral Vascular Devices Market Size 2032 USD 4,186.91 million

Market Overview

The Europe Peripheral Vascular Devices Market is expected to grow from USD 2,656.83 million in 2023 to USD 4,186.91 million by 2032, with a CAGR of 5.85%.

The Europe Peripheral Vascular Devices market is driven by the increasing prevalence of peripheral artery diseases (PAD), rising geriatric populations, and advancements in minimally invasive procedures. Growing awareness about the benefits of early diagnosis and treatment of vascular conditions is further boosting demand. Additionally, the availability of technologically advanced devices, such as drug-coated balloons and stents, contributes to the market’s expansion. The increasing adoption of these devices for their superior outcomes and shorter recovery times is fueling growth. Furthermore, supportive government initiatives and reimbursement policies in European countries are making treatments more accessible. The trend towards outpatient procedures and growing preference for non-surgical treatment methods are also pivotal in shaping the market’s future. Key market players are focusing on expanding their product offerings and enhancing device efficacy to cater to the rising demand for innovative and cost-effective solutions in vascular care.

The Europe Peripheral Vascular Devices market is characterized by strong demand across multiple regions, including Western Europe, Eastern Europe, Northern Europe, and Southern Europe. Western Europe, led by countries such as Germany, the UK, and France, dominates the market due to advanced healthcare infrastructure and a high prevalence of peripheral vascular diseases. Eastern Europe, particularly Poland and Russia, is experiencing rapid growth due to improving medical facilities and increasing awareness. Key players in the market include Medtronic plc, Becton, Dickinson and Company, Biotronik SE & Co. KG, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Cook Medical, Straub Medical AG, Eurocor Tech GmbH, and AngioDynamics, Inc. These companies are investing in innovative technologies such as drug-eluting stents, angioplasty balloons, and minimally invasive procedures to cater to the growing demand for peripheral vascular treatments. Their presence across diverse regions ensures widespread access to advanced vascular devices.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Insights

  • The Europe Peripheral Vascular Devices market was valued at USD 2,656.83 million in 2023 and is expected to reach USD 4,186.91 million by 2032, growing at a CAGR of 5.85%.
  • Increasing prevalence of peripheral vascular diseases (PVD) due to an aging population is driving market growth.
  • Technological advancements in devices like drug-eluting stents and minimally invasive procedures are enhancing treatment efficacy.
  • Growing demand for minimally invasive treatments is transforming the market landscape, reducing recovery times and improving patient outcomes.
  • High device costs and regulatory hurdles may slow market adoption, especially in emerging European countries.
  • Key players like Medtronic, Boston Scientific, and Terumo are leading the market with innovative products and strategic partnerships.
  • Western Europe holds the largest market share, followed by Eastern and Northern Europe, with growing investments in healthcare infrastructure across regions.

Market Drivers

Growing Prevalence of Peripheral Vascular Diseases (PVD)

The increasing prevalence of peripheral vascular diseases (PVD) is a significant driver of the Europe Peripheral Vascular Devices market. PVD, which affects a large portion of the aging population, results from a narrowing of blood vessels outside the heart and brain, often caused by atherosclerosis. For instance, a study published in The Lancet Global Health reported that in 2019, the number of people aged 40 years and older with peripheral artery disease in Europe was approximately 13 million. As the European population ages, the incidence of PVD is expected to rise, thus increasing the demand for effective vascular interventions. Peripheral vascular devices play a crucial role in treating these conditions, driving market growth.

Increased Healthcare Expenditure in Europe

Rising healthcare expenditure in Europe contributes to the growth of the peripheral vascular devices market. European countries are allocating higher budgets to healthcare, recognizing the importance of investing in advanced medical technologies. For instance, according to Eurostat, Germany had the highest level of current healthcare expenditure among EU countries, valued at €489 billion in 2022. With better reimbursement policies and growing awareness about the benefits of early detection and treatment of vascular diseases, more patients are able to access cutting-edge peripheral vascular treatments. This shift is creating a favorable environment for the market to flourish.

Advancements in Technology and Product Innovation

Technological advancements and innovations in peripheral vascular devices are propelling the market’s expansion. Companies are focusing on developing minimally invasive, highly efficient devices with improved functionalities, such as drug-eluting stents and advanced catheter technologies. These innovations enhance treatment outcomes, reduce procedural risks, and shorten recovery times, making these devices more attractive to both patients and healthcare providers. This ongoing technological progression is expected to continue fueling market growth.

Growing Awareness and Early Diagnosis

The increasing awareness about vascular health and the importance of early diagnosis has led to more patients seeking timely treatment, further driving demand for peripheral vascular devices. Governments and healthcare organizations in Europe are focusing on public health campaigns to educate people on the risks of PVD and its symptoms. Early diagnosis enables healthcare professionals to intervene more effectively, preventing the progression of the disease and thereby increasing the need for peripheral vascular devices in treatment protocols.

Market Trends

Integration of Artificial Intelligence (AI) and Robotics

The integration of artificial intelligence (AI) and robotics into peripheral vascular treatments is another emerging trend in the European market. For instance, according to research, approximately 7,754 healthcare companies across Europe have integrated AI in some form. AI-powered devices are being used for improved diagnostics, treatment planning, and procedural guidance. For example, Siemens Healthineers’ Corindus Vascular Robotics system, CorPath GRX, has been used to perform robot-assisted stent implantation in Germany, demonstrating enhanced precision and reduced procedural times. Robotics, on the other hand, enables greater precision during surgeries, reducing human error and enhancing patient outcomes. As these technologies continue to evolve, they are likely to play a crucial role in transforming peripheral vascular interventions, further fueling the demand for advanced devices in the region.

Rise in Adoption of Minimally Invasive Procedures

A key trend in the Europe Peripheral Vascular Devices market is the increasing adoption of minimally invasive procedures. These procedures, such as angioplasty and endovenous laser treatments, are gaining popularity due to their reduced recovery times, lower risk of complications, and shorter hospital stays compared to traditional surgical interventions. As patients and healthcare providers recognize the benefits of minimally invasive methods, the demand for advanced peripheral vascular devices, including stents, balloons, and catheters, is expected to rise, contributing to market growth.

Growing Demand for Drug-Eluting Devices

Drug-eluting devices are witnessing a surge in demand in the European market, driven by their ability to deliver therapeutic agents directly to the treated area. These devices, which combine the mechanical benefits of traditional vascular devices with the added advantage of drug delivery, reduce restenosis and improve long-term outcomes. As healthcare providers increasingly opt for devices that offer both efficacy and safety, the demand for drug-eluting stents and drug-coated balloons is expected to continue growing in Europe.

Shift Toward Patient-Centric Solutions

Patient-centric care is a significant trend in the European peripheral vascular devices market. Healthcare providers are focusing on offering solutions that cater to the specific needs of individual patients, particularly with regard to minimizing pain and enhancing recovery times. Devices that offer greater comfort, flexibility, and efficiency are gaining favor. This trend is leading to the development of advanced peripheral vascular devices that are not only more effective but also tailored to improve patient experiences, thereby supporting market expansion.

Market Challenges Analysis

High Cost of Advanced Devices

One of the major challenges in the Europe Peripheral Vascular Devices market is the high cost of advanced devices. While cutting-edge technologies, such as drug-eluting stents and robotic-assisted interventions, offer superior outcomes, they come with substantial costs. For instance, the average cost of a drug-eluting stent in Europe can range from €1,000 to €2,000. This can strain healthcare budgets, particularly in countries with limited reimbursement policies. The high cost of these devices may also limit their accessibility for patients, especially in public healthcare systems. As a result, healthcare providers face pressure to balance technological advancements with cost-effectiveness, potentially restricting the widespread adoption of certain peripheral vascular devices.

Regulatory and Reimbursement Issues

Regulatory hurdles and reimbursement challenges pose another significant obstacle to the growth of the peripheral vascular devices market in Europe. The regulatory approval process for new devices is often complex and time-consuming, which can delay the entry of innovative products into the market. For example, obtaining CE Mark approval for a new medical device in Europe can take several months and cost upwards of €50,000. Additionally, reimbursement policies across different European countries vary, creating inconsistencies in the affordability and accessibility of these devices. In some cases, reimbursement rates for peripheral vascular treatments may not fully cover the costs of advanced devices, making it difficult for both patients and healthcare providers to justify the investment in newer technologies. These regulatory and reimbursement barriers can hinder market expansion and slow the adoption of life-saving vascular interventions.

Market Opportunities

Expansion of Emerging Markets in Europe

One of the key opportunities in the Europe Peripheral Vascular Devices market lies in the expansion of emerging markets within the region. Countries in Eastern Europe, such as Poland, Hungary, and Romania, are experiencing an increase in healthcare investments and improvements in medical infrastructure. With a growing patient base and the rising incidence of peripheral vascular diseases, these markets present untapped opportunities for manufacturers to introduce advanced peripheral vascular devices. As these nations continue to adopt modern healthcare practices, the demand for innovative, minimally invasive devices is expected to grow, offering significant potential for market expansion.

Increasing Focus on Preventative Healthcare and Early Diagnosis

The increasing emphasis on preventative healthcare and early diagnosis presents another opportunity for the Europe Peripheral Vascular Devices market. As European governments and healthcare organizations shift focus toward early detection of vascular diseases, the demand for diagnostic tools and interventions is expected to rise. Public health campaigns and patient education programs are raising awareness about the importance of managing peripheral vascular diseases at an early stage. This shift toward preventative care will drive the adoption of advanced devices such as diagnostic catheters and stents, creating a long-term growth opportunity for manufacturers. The integration of advanced technologies such as artificial intelligence and machine learning in diagnostic and treatment devices further enhances this opportunity, enabling more efficient and accurate interventions.

Market Segmentation Analysis:

By Type:

The Europe Peripheral Vascular Devices market is primarily segmented by type into angioplasty balloons, angioplasty stents, catheters, guidewires, and others. Angioplasty balloons hold a significant share due to their pivotal role in minimally invasive procedures for treating peripheral artery diseases (PAD). These balloons are often used in conjunction with stents, which are designed to keep blood vessels open post-procedure. Angioplasty stents, particularly drug-eluting varieties, are increasingly popular for their ability to reduce restenosis rates and improve long-term patient outcomes. Catheters and guidewires are also essential for ensuring the success of vascular interventions by providing access to blocked arteries and guiding the placement of devices. Other peripheral vascular devices include thrombectomy devices, which are used for removing blood clots, and diagnostic tools for early detection. The growing adoption of minimally invasive procedures across Europe is driving the demand for these devices, especially as healthcare providers look to reduce recovery times and improve patient outcomes.

By End-user:

The end-user segment of the Europe Peripheral Vascular Devices market includes hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Hospitals dominate the market, as they are equipped with advanced medical technologies and offer comprehensive healthcare services, including specialized vascular treatments. Ambulatory surgical centers are experiencing rapid growth due to their ability to perform outpatient procedures at lower costs. ASCs provide a viable alternative to hospital-based care, especially for minimally invasive surgeries like angioplasty. Specialty clinics, focusing on vascular and cardiology care, are also a growing segment, providing targeted treatments for peripheral vascular diseases. As the demand for peripheral vascular interventions increases, these end-users are likely to expand, enhancing the adoption of advanced devices. Moreover, the preference for outpatient and cost-effective care is pushing more patients toward ASCs and specialty clinics, further driving the demand for peripheral vascular devices in these settings.

Segments:

Based on Type:

  • Angioplasty Balloons
  • Angioplasty Stents
  • Catheters
  • Guidewires
  • Others

Based on End-user:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Based on the Geography:

  • UK
  • France
  • Germany
  • Italy
  • Spain
  • Russia
  • Belgium
  • Netherlands
  • Austria
  • Sweden
  • Poland
  • Denmark
  • Switzerland
  • Rest of Europe

Regional Analysis

Western Europe

Western Europe accounts for a significant portion of the Europe Peripheral Vascular Devices market, with countries like the UK, France, Germany, and Italy leading the way. In 2023, Western Europe held a market share of approximately 55%. The demand for peripheral vascular devices in this region is driven by the growing prevalence of peripheral vascular diseases (PVD), an aging population, and the increasing adoption of minimally invasive procedures. Germany holds the largest market share within Western Europe, followed by France and the UK, which benefit from advanced healthcare systems and high patient awareness. Additionally, these countries have well-established reimbursement policies that support the affordability and accessibility of peripheral vascular treatments. As the demand for innovative and minimally invasive vascular devices continues to rise, the Western European market is expected to maintain strong growth over the forecast period.

Eastern Europe

Eastern Europe, encompassing countries like Poland, Russia, and Hungary, is experiencing significant market expansion, capturing around 20% of the Europe Peripheral Vascular Devices market in 2023. This growth is fueled by increasing healthcare investments, improving infrastructure, and a rising incidence of vascular diseases. In particular, Russia and Poland are showing higher adoption rates of advanced medical technologies, including peripheral vascular devices. The demand is further supported by favorable government policies and rising patient awareness. However, reimbursement and cost-related challenges may limit the speed of adoption in some areas. Despite these hurdles, the growing focus on cardiovascular health and improved medical accessibility is expected to bolster the market in Eastern Europe over the next several years.

Northern Europe

Northern Europe, which includes countries like Sweden, Denmark, and Finland, holds a market share of approximately 12% in the Europe Peripheral Vascular Devices market as of 2023. The region’s advanced healthcare infrastructure and high standard of living contribute to the growing demand for peripheral vascular devices. In particular, Sweden and Denmark are notable for their efficient healthcare systems, which ensure that peripheral vascular treatments are widely accessible. Additionally, the increasing prevalence of peripheral vascular diseases in an aging population is driving the demand for advanced vascular devices. The preference for minimally invasive treatments, combined with high levels of awareness and well-established healthcare policies, supports sustained market growth in Northern Europe.

Southern Europe

Southern Europe, including Italy, Spain, and Greece, holds a market share of approximately 13% of the Europe Peripheral Vascular Devices market in 2023. The region is seeing a steady rise in demand for peripheral vascular devices due to the growing prevalence of diabetes, hypertension, and other risk factors for peripheral artery diseases (PAD). Italy and Spain are the leading contributors to the Southern European market, with increasing investments in healthcare infrastructure and an emphasis on adopting advanced medical technologies. Furthermore, Southern European countries are focusing on improving healthcare accessibility, which is expected to drive the growth of the peripheral vascular devices market in the coming years. Although economic factors may pose challenges in some regions, the expanding healthcare sector and rising awareness will continue to support market growth.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Player Analysis

  • Medtronic plc
  • Becton, Dickinson and Company
  • Biotronik SE & Co. KG
  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • Terumo Corporation
  • Cook Medical
  • Straub Medical AG
  • Eurocor Tech GmbH
  • AngioDynamics, Inc.

Competitive Analysis

The Europe Peripheral Vascular Devices market is highly competitive, with several leading players focusing on technological innovations and strategic collaborations to maintain market leadership. Medtronic plc, Becton, Dickinson and Company, Biotronik SE & Co. KG, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Cook Medical, Straub Medical AG, Eurocor Tech GmbH, and AngioDynamics, Inc. are among the prominent companies driving market growth. Leading players in the market are continuously developing new products, enhancing their portfolios, and expanding their geographic reach to meet the growing demand for peripheral vascular treatments. For instance, Medtronic’s HawkOne™ directional atherectomy system is designed to treat above and below the knee by removing plaque in patients with peripheral arterial disease (PAD). Many of these companies are investing heavily in research and development to introduce innovative solutions such as drug-eluting stents, minimally invasive procedures, and advanced diagnostic devices. In addition, several companies are pursuing strategic partnerships and acquisitions to enhance their product offerings and strengthen their market presence. These efforts not only help in diversifying their portfolios but also improve their ability to cater to the increasing demand for advanced vascular treatments. Companies are also focusing on improving patient outcomes by incorporating cutting-edge technologies like artificial intelligence and robotic assistance in vascular surgeries. As a result, competition remains intense, with businesses competing on factors such as product quality, technological innovation, and pricing strategies to capture a larger share of the market. The increasing focus on minimally invasive treatments and patient-centric care continues to drive innovation and shape the competitive landscape in the European peripheral vascular devices market.

Recent Developments

  • In December 2024, Terumo Interventional Systems launched the R2P™ NaviCross® peripheral support catheter in the U.S. This catheter is designed for enhanced performance in radial-to-peripheral procedures, addressing the need for advanced tools in treating PAD and critical limb ischemia.
  • In October 2024, BD was highlighted as a key player in the peripheral vascular devices market forecast report. While specific recent product launches were not detailed, BD’s ongoing commitment to R&D and innovation positions it strongly within this competitive landscape.
  • In June 2023, Cook Medical announced new size options for its Advance Serenity PTA Balloon Catheter, used for treating peripheral artery disease (PAD).
  • In June 2023, Biotronik launched the Oscar multifunctional peripheral catheter, designed for dilation of stenotic segments in peripheral vessels. The device features user-adjustable components and aims to improve procedural efficiency in treating peripheral arterial disease.

Market Concentration & Characteristics

The Europe Peripheral Vascular Devices market exhibits moderate concentration, with a few key players holding significant market shares while smaller companies continue to innovate and cater to niche segments. This dynamic creates a competitive environment where large companies dominate with their established brands, broad product portfolios, and strong distribution networks. These industry leaders focus on technological advancements, regulatory compliance, and strategic partnerships to maintain their market position. Smaller players, on the other hand, often differentiate themselves through specialized products or regional expertise, targeting underserved markets or specific patient needs. The market is characterized by a high level of innovation, particularly in minimally invasive technologies such as drug-eluting stents, angioplasty balloons, and diagnostic devices. Additionally, there is an increasing shift toward patient-centric solutions, with many companies emphasizing ease of use, reduced recovery times, and improved long-term outcomes. This focus on innovation is coupled with growing demand from healthcare providers looking for cost-effective and efficient treatments, further driving market competition. Regulatory frameworks in Europe play a crucial role in shaping market dynamics, with companies needing to comply with stringent standards for device approval. Overall, the market is evolving towards more personalized, minimally invasive solutions that meet the growing healthcare needs of Europe’s aging population.

Report Coverage

The research report offers an in-depth analysis based on Type, End-user and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. The Europe Peripheral Vascular Devices market is expected to continue growing, driven by an aging population and increasing prevalence of peripheral vascular diseases.
  2. Technological innovations, such as drug-eluting stents and minimally invasive procedures, will continue to shape the future of the market.
  3. The demand for non-invasive and less traumatic treatment options is expected to rise, boosting the adoption of advanced devices.
  4. Market growth will be supported by increased investments in healthcare infrastructure, particularly in Eastern and Southern Europe.
  5. The integration of artificial intelligence and machine learning in diagnostic and treatment devices will enhance the precision and effectiveness of vascular procedures.
  6. Rising patient awareness and improved access to healthcare services will further drive the demand for peripheral vascular treatments.
  7. Companies will focus on expanding their portfolios with advanced products aimed at improving patient outcomes and reducing recovery times.
  8. Reimbursement policies and government initiatives will continue to play a key role in shaping market growth, particularly in emerging regions.
  9. Collaboration and strategic partnerships between key players will accelerate the development and distribution of innovative vascular devices.
  10. As the market evolves, there will be a greater emphasis on personalized treatments and patient-centric care to meet the diverse needs of the European population.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Offerings 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. Peripheral Vascular Devices Market Snapshot 21

2.1.1. Europe Peripheral Vascular Devices Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23

3.1. Russia-Ukraine and Israel-Palestine War Impacts 23

CHAPTER NO. 4 : PERIPHERAL VASCULAR DEVICES MARKET – INDUSTRY ANALYSIS 24

4.1. Introduction 24

4.2. Market Drivers 25

4.2.1. Increasing prevalence of peripheral artery disease and other vascular conditions 25

4.2.2. Technological advancements in minimally invasive procedures 26

4.3. Market Restraints 27

4.3.1. High cost of peripheral vascular devices and associated procedures 27

4.4. Market Opportunities 28

4.4.1. Growing demand for peripheral vascular devices in emerging economies 28

4.5. Porter’s Five Forces Analysis 29

4.6. Buying Criteria 30

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 31

5.1. Import Analysis by Europe 31

5.1.1. Europe Peripheral Vascular Devices Market Import Volume/Revenue, By Europe, 2018 – 2023 31

5.2. Export Analysis by Europe 32

5.2.1. Europe Peripheral Vascular Devices Market Export Volume/Revenue, By Europe, 2018 – 2023 32

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 33

6.1. Demand Analysis by Europe 33

6.1.1. Europe Peripheral Vascular Devices Market Demand Volume/Revenue, By Europe, 2018 – 2023 33

6.2. Supply Analysis by Europe 34

6.2.1. Europe Peripheral Vascular Devices Market Supply Volume/Revenue, By Europe, 2018 – 2023 34

CHAPTER NO. 7 : PRODUCTION ANALYSIS 35

7.1. Production Analysis by Europe 35

7.1.1. Europe Peripheral Vascular Devices Market Production Volume/Revenue, By Europe, 2018 – 2023 35

CHAPTER NO. 8 : PRICE ANALYSIS 36

8.1. Price Analysis by Type 36

8.1.1. Europe Peripheral Vascular Devices Market Price, By Type, 2018 – 2023 36

8.1.2. Europe Type Market Price, By Type, 2018 – 2023 36

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 37

9.1. Key Raw Materials and Suppliers 37

9.2. Key Raw Materials Price Trend 37

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 38

10.1. Manufacturing Cost Analysis 38

10.2. Manufacturing Process 38

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 39

11.1. Company Market Share Analysis – 2023 39

11.2. Value Chain Analysis 39

11.2.1. Europe Peripheral Vascular Devices Market: Company Market Share, by Volume, 2023 40

11.2.2. Europe Peripheral Vascular Devices Market: Company Market Share, by Revenue, 2023 41

11.2.3. Europe Peripheral Vascular Devices Market: Top 6 Company Market Share, by Revenue, 2023 41

11.2.4. Europe Peripheral Vascular Devices Market: Top 3 Company Market Share, by Revenue, 2023 42

11.3. Europe Peripheral Vascular Devices Market Company Volume Market Share, 2023 43

11.4. Europe Peripheral Vascular Devices Market Company Revenue Market Share, 2023 44

11.5. Company Assessment Metrics, 2023 44

11.5.1. Stars 44

11.5.2. Emerging Leaders 44

11.5.3. Pervasive Players 44

11.5.4. Participants 44

11.6. Start-ups /SMEs Assessment Metrics, 2023 44

11.6.1. Progressive Companies 44

11.6.2. Responsive Companies 45

11.6.3. Dynamic Companies 45

11.6.4. Starting Blocks 45

11.7. Strategic Developments 46

11.7.1. Acquisitions & Mergers 46

New Product Launch 46

Europe Expansion 46

11.8. Key Players Product Matrix 47

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 48

12.1. PESTEL 48

12.1.1. Political Factors 48

12.1.2. Economic Factors 48

12.1.3. Social Factors 48

12.1.4. Technological Factors 48

12.1.5. Environmental Factors 48

12.1.6. Legal Factors 48

12.2. Adjacent Market Analysis 48

CHAPTER NO. 13 : PERIPHERAL VASCULAR DEVICES MARKET – BY TYPE SEGMENT ANALYSIS 49

13.1. Peripheral Vascular Devices Market Overview, by Type Segment 49

13.1.1. Peripheral Vascular Devices Market Revenue Share, By Type, 2023 & 2032 50

13.1.2. Peripheral Vascular Devices Market Attractiveness Analysis, By Type 51

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51

13.1.4. Peripheral Vascular Devices Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

13.2. Angioplasty Balloons 53

13.3. Angioplasty Stents 54

13.4. Catheters 55

13.5. Guidewires 56

13.6. Others 57

CHAPTER NO. 14 : PERIPHERAL VASCULAR DEVICES MARKET – BY END-USER SEGMENT ANALYSIS 58

14.1. Peripheral Vascular Devices Market Overview, by End-user Segment 58

14.1.1. Peripheral Vascular Devices Market Revenue Share, By End-user, 2023 & 2032 59

14.1.2. Peripheral Vascular Devices Market Attractiveness Analysis, By End-user 60

14.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 60

14.1.4. Peripheral Vascular Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 61

14.2. Hospitals 62

14.3. Ambulatory Surgical Centers 63

14.4. Specialty Clinics 64

CHAPTER NO. 15 : PERIPHERAL VASCULAR DEVICES MARKET – EUROPE ANALYSIS 65

15.1. Type 65

15.1.1. Europe Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 (USD Million) 65

15.2. Europe Peripheral Vascular Devices Market Revenue, By Type, 2024 – 2032 (USD Million) 65

15.3. End-user 66

15.3.1. Europe Peripheral Vascular Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 66

15.3.2. Europe Peripheral Vascular Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 66

15.4. UK 66

15.5. France 66

15.6. Germany 66

15.7. Italy 66

15.8. Spain 66

15.9. Russia 66

15.10. Belgium 66

15.11. Netherland 66

15.12. Austria 67

15.13. Sweden 67

15.14. Poland 67

15.15. Denmark 67

15.16. Switzerland 67

15.17. Rest of Europe 67

CHAPTER NO. 16 : COMPANY PROFILES 68

16.1. Medtronic plc 68

16.1.1. Company Overview 68

16.1.2. Product Portfolio 68

16.1.3. Swot Analysis 68

16.1.4. Business Strategy 69

16.1.5. Financial Overview 69

16.2. Becton, Dickinson and Company 70

16.3. Biotronik SE & Co. KG 70

16.4. Koninklijke Philips N.V. 70

16.5. Boston Scientific Corporation 70

16.6. Terumo Corporation 70

16.7. Cook Medical 70

16.8. Straub Medical AG 70

16.9. Eurocor Tech GmbH 70

16.10. AngioDynamics, Inc. 70

List of Figures

FIG NO. 1. Europe Peripheral Vascular Devices Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for Europe Peripheral Vascular Devices Market 29

FIG NO. 3. Europe Peripheral Vascular Devices Market Import Volume/Revenue, By Europe, 2018 – 2023 31

FIG NO. 4. Europe Peripheral Vascular Devices Market Export Volume/Revenue, By Europe, 2018 – 2023 32

FIG NO. 5. Europe Peripheral Vascular Devices Market Demand Volume/Revenue, By Europe, 2018 – 2023 33

FIG NO. 6. Europe Peripheral Vascular Devices Market Supply Volume/Revenue, By Europe, 2018 – 2023 34

FIG NO. 7. Europe Peripheral Vascular Devices Market Production Volume/Revenue, By Europe, 2018 – 2023 35

FIG NO. 8. Europe Peripheral Vascular Devices Market Price, By Type, 2018 – 2023 36

FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37

FIG NO. 10. Manufacturing Cost Analysis 38

FIG NO. 11. Manufacturing Process 38

FIG NO. 12. Value Chain Analysis for Europe Peripheral Vascular Devices Market 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. Peripheral Vascular Devices Market – Company Volume  Market Share, 2023 43

FIG NO. 18. Peripheral Vascular Devices Market – Company Revenue Market Share, 2023 44

FIG NO. 19. Peripheral Vascular Devices Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. Peripheral Vascular Devices Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. Europe Peripheral Vascular Devices Market for Angioplasty Balloons, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. Europe Peripheral Vascular Devices Market for Angioplasty Stents, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. Europe Peripheral Vascular Devices Market for Catheters, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. Europe Peripheral Vascular Devices Market for Guidewires, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. Europe Peripheral Vascular Devices Market for Others, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. Peripheral Vascular Devices Market Revenue Share, By End-user, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By End-user 60

FIG NO. 30. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 60

FIG NO. 31. Peripheral Vascular Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 61

FIG NO. 32. Europe Peripheral Vascular Devices Market for Hospitals, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. Europe Peripheral Vascular Devices Market for Ambulatory Surgical Centers, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. Europe Peripheral Vascular Devices Market for Specialty Clinics, Revenue (USD Million) 2018 – 2032 64

List of Tables

TABLE NO. 1. : Europe Peripheral Vascular Devices Market: Snapshot 21

TABLE NO. 2. : Drivers for the Peripheral Vascular Devices Market: Impact Analysis 25

TABLE NO. 3. : Restraints for the Peripheral Vascular Devices Market: Impact Analysis 27

TABLE NO. 4. : Europe Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 36

TABLE NO. 5. : Key Raw Materials & Suppliers 37

TABLE NO. 6. : Europe Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 (USD Million) 65

TABLE NO. 7. : Europe Peripheral Vascular Devices Market Revenue, By Type, 2024 – 2032 (USD Million) 65

TABLE NO. 8. : Europe Peripheral Vascular Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 66

TABLE NO. 9. : Europe Peripheral Vascular Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 66

 

Frequently Asked Questions

What is the current size of the Europe Peripheral Vascular Devices market?

The Europe Peripheral Vascular Devices market is valued at USD 2,656.83 million in 2023 and is projected to grow to USD 4,186.91 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.85%.

What factors are driving the growth of the Europe Peripheral Vascular Devices market?

The market’s growth is driven by the increasing prevalence of peripheral artery diseases (PAD), advancements in minimally invasive procedures, and the availability of technologically advanced devices such as drug-coated balloons and stents. Additionally, rising healthcare expenditure, supportive government initiatives, and growing awareness of early diagnosis and treatment of vascular conditions are further fueling demand.

What are the key segments within the Europe Peripheral Vascular Devices market?

The market is segmented by type into angioplasty balloons, angioplasty stents, catheters, guidewires, and others. It is also segmented by end-user into hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Geographically, the market is divided into Western Europe, Eastern Europe, Northern Europe, Southern Europe, and the Rest of Europe.

What are some challenges faced by the Europe Peripheral Vascular Devices market?

The market faces challenges such as the high cost of advanced devices like drug-eluting stents and robotic-assisted interventions, which can strain healthcare budgets. Regulatory hurdles and inconsistent reimbursement policies across European countries also pose significant obstacles, potentially slowing the adoption of innovative devices.

Who are the major players in the Europe Peripheral Vascular Devices market?

Key players in the market include Medtronic plc, Becton, Dickinson and Company, Biotronik SE & Co. KG, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Cook Medical, Straub Medical AG, Eurocor Tech GmbH, and AngioDynamics, Inc. These companies focus on product innovation, strategic partnerships, and expanding their portfolios to cater to growing demand.

Europe Data Center Renovation Market

Published:
Report ID: 75495

Europe AC-DC Power Supply in Data Center Market

Published:
Report ID: 75202

Europe Data Center Processor Market

Published:
Report ID: 74948

Europe High-End Beef Market

Published:
Report ID: 74813

Europe Meat Analyzer Market

Published:
Report ID: 74724

Europe Meat enhancer Market

Published:
Report ID: 74635

Europe Grid Modernization Market

Published:
Report ID: 73479

Europe Data Center Physical Security Market

Published:
Report ID: 73469

Europe Destination Wedding Market

Published:
Report ID: 73351

Endoscopic Vessel Harvesting Systems Market

Published:
Report ID: 4328

South Africa Medical Gas and Equipment Market

Published:
Report ID: 75642

Compliance Monitoring Devices Market

Published:
Report ID: 75564

Continuous Glucose Monitoring Devices Market

Published:
Report ID: 4258

Internal Radiation Therapy Market

Published:
Report ID: 75411

Image Guided Radiotherapy Market

Published:
Report ID: 75382

Flat Panel X-Ray Detectors Market

Published:
Report ID: 74896

Hemostasis Testing Systems Market

Published:
Report ID: 74856

Cardiac Ultrasound Systems Market

Published:
Report ID: 74702

Aesthetic Medical Devices Market

Published:
Report ID: 74587

Italy Diabetes Care Devices Market

Published:
Report ID: 64898

Transplant Monitoring Kits Market

Published:
Report ID: 74464

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$3699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$4699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$6699

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN